CCPG1

Across TCGA pan-cancer cohorts, CCPG1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CCPG1’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where CCPG1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CCPG1 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

CCRCC, LUAD, and HNSC are the cancer types where CCPG1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCPG1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	IV	+0.967	<.001	11	view →
LUAD	Female	II,III,IV	+0.496	<.001	9	view →
HNSC	Male	III,IV	+0.250	.010	7	view →
PDAC	Male	All	−0.828	<.001	6	view →
LSCC	Female	All	+0.381	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CCPG1–CCRCC

Open the CCRCC breakdown →